Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.

about

Males with prolactinoma are at increased risk of incident cardiovascular disease.

P2860

Q47606133-73391BA6-4F00-4087-A8CD-57B702CCD95F

P2860

Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.

Item

http://www.wikidata.org/entity/Q38386992

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of bromocriptine-QR the ...... ellitus subjects on metformin.

@en

type

Item

label

Impact of bromocriptine-QR the ...... ellitus subjects on metformin.

@en

prefLabel

Impact of bromocriptine-QR the ...... ellitus subjects on metformin.

@en

P1476

Impact of bromocriptine-QR the ...... ellitus subjects on metformin.

@en

P2093

Anthony H Cincotta

http://www.w3.org/2001/XMLSchema#string

Bindu Chamarthi

http://www.w3.org/2001/XMLSchema#string

Dean Rutty

http://www.w3.org/2001/XMLSchema#string

Michael Ezrokhi

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.

Elevated heart rate as a predictor of increased cardiovascular morbidity.

The relationship of plasma volume, sympathetic tone, and proinflammatory cytokines in young healthy nonpregnant women.

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.

Sympathetic nervous system, diabetes, and hypertension.

The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations.

Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease.

Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene

The immune system and hypertension.

P304

761-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2016.1243003

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27687032

http://www.w3.org/2001/XMLSchema#string

P921

metformin

Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.

about

P2860

P2860

Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921